TWI698526B - 利用合成之信使ｒｎａ進行之人類誘導型多能幹細胞之無餵養細胞衍化（ｄｅｒｉｖａｔｉｏｎ） - Google Patents

利用合成之信使ｒｎａ進行之人類誘導型多能幹細胞之無餵養細胞衍化（ｄｅｒｉｖａｔｉｏｎ） Download PDF

Info

Publication number: TWI698526B
Authority: TW; Taiwan
Prior art keywords: cells; reprogramming; mrna; cell; feeder
Prior art date: 2014-05-30

Application number

TW104117573A

Other languages

English (en)

Chinese (zh)

Other versions

TW201600605A (zh

Inventor

繼武王

Original Assignee

美商綠陽生物科技及製藥公司

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-05-30

Filing date

2015-05-29

Publication date

2020-07-11

2014-05-30 Priority claimed from US14/292,317 external-priority patent/US10119150B2/en

2015-05-29 Application filed by 美商綠陽生物科技及製藥公司 filed Critical 美商綠陽生物科技及製藥公司

2016-01-01 Publication of TW201600605A publication Critical patent/TW201600605A/zh

2020-07-11 Application granted granted Critical

2020-07-11 Publication of TWI698526B publication Critical patent/TWI698526B/zh

Links

108020004999 messenger RNA Proteins 0.000 title claims abstract description 115
210000004263 induced pluripotent stem cell Anatomy 0.000 title claims abstract description 60
241000282414 Homo sapiens Species 0.000 title claims abstract description 52
238000009795 derivation Methods 0.000 title abstract description 10
210000004027 cell Anatomy 0.000 claims abstract description 291
238000000034 method Methods 0.000 claims abstract description 104
230000008672 reprogramming Effects 0.000 claims abstract description 102
239000000203 mixture Substances 0.000 claims abstract description 61
230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 claims abstract description 17
210000004962 mammalian cell Anatomy 0.000 claims abstract description 12
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 49
238000001890 transfection Methods 0.000 claims description 40
210000001082 somatic cell Anatomy 0.000 claims description 18
238000000338 in vitro Methods 0.000 claims description 11
241000282693 Cercopithecidae Species 0.000 claims description 10
101001023030 Toxoplasma gondii Myosin-D Proteins 0.000 claims description 9
238000006243 chemical reaction Methods 0.000 claims description 8
108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 claims description 7
101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 claims description 6
238000013518 transcription Methods 0.000 claims description 6
230000035897 transcription Effects 0.000 claims description 6
101100411708 Danio rerio rarga gene Proteins 0.000 claims description 5
108700021430 Kruppel-Like Factor 4 Proteins 0.000 claims description 5
ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 claims description 5
230000001939 inductive effect Effects 0.000 claims description 4
241000894007 species Species 0.000 claims description 4
101100239628 Danio rerio myca gene Proteins 0.000 claims description 3
-1 Nanog Proteins 0.000 claims description 3
230000002159 abnormal effect Effects 0.000 claims description 3
101150111214 lin-28 gene Proteins 0.000 claims description 3
241000282465 Canis Species 0.000 claims description 2
230000004913 activation Effects 0.000 claims description 2
230000032459 dedifferentiation Effects 0.000 claims description 2
241000283690 Bos taurus Species 0.000 claims 1
241000283073 Equus caballus Species 0.000 claims 1
241000282560 Macaca mulatta Species 0.000 claims 1
241001504519 Papio ursinus Species 0.000 claims 1
241001494479 Pecora Species 0.000 claims 1
210000002950 fibroblast Anatomy 0.000 abstract description 43
230000004927 fusion Effects 0.000 abstract description 10
230000008569 process Effects 0.000 abstract description 9
108090000623 proteins and genes Proteins 0.000 description 29
210000000130 stem cell Anatomy 0.000 description 25
102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 19
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
201000010099 disease Diseases 0.000 description 18
239000002609 medium Substances 0.000 description 17
102000039446 nucleic acids Human genes 0.000 description 16
108020004707 nucleic acids Proteins 0.000 description 16
150000007523 nucleic acids Chemical class 0.000 description 16
210000001519 tissue Anatomy 0.000 description 16
101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 14
238000002474 experimental method Methods 0.000 description 14
210000003958 hematopoietic stem cell Anatomy 0.000 description 14
239000002679 microRNA Substances 0.000 description 14
108020004414 DNA Proteins 0.000 description 13
239000002299 complementary DNA Substances 0.000 description 12
239000000047 product Substances 0.000 description 12
102100038895 Myc proto-oncogene protein Human genes 0.000 description 11
230000004069 differentiation Effects 0.000 description 11
239000013598 vector Substances 0.000 description 11
239000000243 solution Substances 0.000 description 10
108700011259 MicroRNAs Proteins 0.000 description 9
102000004169 proteins and genes Human genes 0.000 description 9
101001128090 Homo sapiens Homeobox protein NANOG Proteins 0.000 description 8
108050000630 Transcription factor SOX-2 Proteins 0.000 description 8
102100024270 Transcription factor SOX-2 Human genes 0.000 description 8
230000000694 effects Effects 0.000 description 8
230000014509 gene expression Effects 0.000 description 8
239000000463 material Substances 0.000 description 8
239000002773 nucleotide Substances 0.000 description 8
125000003729 nucleotide group Chemical group 0.000 description 8
102000040650 (ribonucleotides)n+m Human genes 0.000 description 7
101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 description 7
101000984042 Homo sapiens Protein lin-28 homolog A Proteins 0.000 description 7
102100020677 Krueppel-like factor 4 Human genes 0.000 description 7
102000055601 Nanog Homeobox Human genes 0.000 description 7
238000005516 engineering process Methods 0.000 description 7
210000002706 plastid Anatomy 0.000 description 7
239000002243 precursor Substances 0.000 description 7
101710135898 Myc proto-oncogene protein Proteins 0.000 description 6
108700026244 Open Reading Frames Proteins 0.000 description 6
102100025460 Protein lin-28 homolog A Human genes 0.000 description 6
101710150448 Transcriptional regulator Myc Proteins 0.000 description 6
238000004458 analytical method Methods 0.000 description 6
108091070501 miRNA Proteins 0.000 description 6
230000004048 modification Effects 0.000 description 6
238000012986 modification Methods 0.000 description 6
210000003205 muscle Anatomy 0.000 description 6
238000012360 testing method Methods 0.000 description 6
101150023320 B16R gene Proteins 0.000 description 5
101001030211 Homo sapiens Myc proto-oncogene protein Proteins 0.000 description 5
101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 description 5
101100316831 Vaccinia virus (strain Copenhagen) B18R gene Proteins 0.000 description 5
101100004099 Vaccinia virus (strain Western Reserve) VACWR200 gene Proteins 0.000 description 5
201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
230000001976 improved effect Effects 0.000 description 5
230000001965 increasing effect Effects 0.000 description 5
230000001105 regulatory effect Effects 0.000 description 5
230000001225 therapeutic effect Effects 0.000 description 5
238000011282 treatment Methods 0.000 description 5
108020004459 Small interfering RNA Proteins 0.000 description 4
230000024932 T cell mediated immunity Effects 0.000 description 4
208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 4
102000040945 Transcription factor Human genes 0.000 description 4
108091023040 Transcription factor Proteins 0.000 description 4
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
241000700605 Viruses Species 0.000 description 4
230000008901 benefit Effects 0.000 description 4
238000012258 culturing Methods 0.000 description 4
210000003494 hepatocyte Anatomy 0.000 description 4
210000005260 human cell Anatomy 0.000 description 4
238000012744 immunostaining Methods 0.000 description 4
239000000543 intermediate Substances 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
201000006417 multiple sclerosis Diseases 0.000 description 4
210000002569 neuron Anatomy 0.000 description 4
238000010899 nucleation Methods 0.000 description 4
210000002997 osteoclast Anatomy 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
230000002207 retinal effect Effects 0.000 description 4
238000001356 surgical procedure Methods 0.000 description 4
230000004083 survival effect Effects 0.000 description 4
239000012096 transfection reagent Substances 0.000 description 4
239000013603 viral vector Substances 0.000 description 4
OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 3
108700028369 Alleles Proteins 0.000 description 3
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
108010077544 Chromatin Proteins 0.000 description 3
239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
241000699666 Mus <mouse, genus> Species 0.000 description 3
108091034117 Oligonucleotide Proteins 0.000 description 3
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
210000001789 adipocyte Anatomy 0.000 description 3
239000003242 anti bacterial agent Substances 0.000 description 3
229940088710 antibiotic agent Drugs 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
229910052791 calcium Inorganic materials 0.000 description 3
239000011575 calcium Substances 0.000 description 3
230000008859 change Effects 0.000 description 3
210000003483 chromatin Anatomy 0.000 description 3
230000002354 daily effect Effects 0.000 description 3
201000001981 dermatomyositis Diseases 0.000 description 3
210000001671 embryonic stem cell Anatomy 0.000 description 3
210000003527 eukaryotic cell Anatomy 0.000 description 3
230000003203 everyday effect Effects 0.000 description 3
230000002068 genetic effect Effects 0.000 description 3
230000012010 growth Effects 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
230000006872 improvement Effects 0.000 description 3
230000006698 induction Effects 0.000 description 3
230000002401 inhibitory effect Effects 0.000 description 3
238000011081 inoculation Methods 0.000 description 3
210000004698 lymphocyte Anatomy 0.000 description 3
210000002901 mesenchymal stem cell Anatomy 0.000 description 3
230000035755 proliferation Effects 0.000 description 3
210000002460 smooth muscle Anatomy 0.000 description 3
210000001057 smooth muscle myoblast Anatomy 0.000 description 3
239000000126 substance Substances 0.000 description 3
230000009469 supplementation Effects 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
201000004384 Alopecia Diseases 0.000 description 2
208000024827 Alzheimer disease Diseases 0.000 description 2
241000180579 Arca Species 0.000 description 2
108091026821 Artificial microRNA Proteins 0.000 description 2
208000000659 Autoimmune lymphoproliferative syndrome Diseases 0.000 description 2
241000271566 Aves Species 0.000 description 2
108091032955 Bacterial small RNA Proteins 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
102100030074 Dickkopf-related protein 1 Human genes 0.000 description 2
101710099518 Dickkopf-related protein 1 Proteins 0.000 description 2
208000001640 Fibromyalgia Diseases 0.000 description 2
208000007465 Giant cell arteritis Diseases 0.000 description 2
208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 2
241000282412 Homo Species 0.000 description 2
206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 2
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
102000014150 Interferons Human genes 0.000 description 2
108010050904 Interferons Proteins 0.000 description 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
241000711408 Murine respirovirus Species 0.000 description 2
108700020796 Oncogene Proteins 0.000 description 2
208000012868 Overgrowth Diseases 0.000 description 2
206010034277 Pemphigoid Diseases 0.000 description 2
241000283984 Rodentia Species 0.000 description 2
108700019146 Transgenes Proteins 0.000 description 2
208000036142 Viral infection Diseases 0.000 description 2
101710101493 Viral myc transforming protein Proteins 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
239000000556 agonist Substances 0.000 description 2
231100000360 alopecia Toxicity 0.000 description 2
230000003321 amplification Effects 0.000 description 2
230000006907 apoptotic process Effects 0.000 description 2
238000013459 approach Methods 0.000 description 2
210000000601 blood cell Anatomy 0.000 description 2
210000001772 blood platelet Anatomy 0.000 description 2
239000000872 buffer Substances 0.000 description 2
210000004413 cardiac myocyte Anatomy 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
238000002512 chemotherapy Methods 0.000 description 2
238000004140 cleaning Methods 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000011109 contamination Methods 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
230000003013 cytotoxicity Effects 0.000 description 2
231100000135 cytotoxicity Toxicity 0.000 description 2
230000007423 decrease Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
238000007865 diluting Methods 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
210000002889 endothelial cell Anatomy 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
210000000981 epithelium Anatomy 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
238000012239 gene modification Methods 0.000 description 2
238000003384 imaging method Methods 0.000 description 2
230000028993 immune response Effects 0.000 description 2
208000026278 immune system disease Diseases 0.000 description 2
230000005847 immunogenicity Effects 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
229940079322 interferon Drugs 0.000 description 2
210000002510 keratinocyte Anatomy 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
210000005228 liver tissue Anatomy 0.000 description 2
206010025135 lupus erythematosus Diseases 0.000 description 2
229910052749 magnesium Inorganic materials 0.000 description 2
239000011777 magnesium Substances 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
239000012913 medium supplement Substances 0.000 description 2
108091007426 microRNA precursor Proteins 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
210000004165 myocardium Anatomy 0.000 description 2
210000000944 nerve tissue Anatomy 0.000 description 2
102000045246 noggin Human genes 0.000 description 2
108700007229 noggin Proteins 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
230000033667 organ regeneration Effects 0.000 description 2
102000040430 polynucleotide Human genes 0.000 description 2
108091033319 polynucleotide Proteins 0.000 description 2
239000002157 polynucleotide Substances 0.000 description 2
238000001959 radiotherapy Methods 0.000 description 2
108700015048 receptor decoy activity proteins Proteins 0.000 description 2
238000011084 recovery Methods 0.000 description 2
238000007634 remodeling Methods 0.000 description 2
239000012679 serum free medium Substances 0.000 description 2
210000004927 skin cell Anatomy 0.000 description 2
238000003860 storage Methods 0.000 description 2
230000035882 stress Effects 0.000 description 2
210000002536 stromal cell Anatomy 0.000 description 2
239000000758 substrate Substances 0.000 description 2
230000001629 suppression Effects 0.000 description 2
208000011580 syndromic disease Diseases 0.000 description 2
238000001308 synthesis method Methods 0.000 description 2
206010043207 temporal arteritis Diseases 0.000 description 2
230000009466 transformation Effects 0.000 description 2
239000001226 triphosphate Substances 0.000 description 2
235000011178 triphosphate Nutrition 0.000 description 2
229940035893 uracil Drugs 0.000 description 2
230000002792 vascular Effects 0.000 description 2
238000012795 verification Methods 0.000 description 2
230000009385 viral infection Effects 0.000 description 2
108020005345 3' Untranslated Regions Proteins 0.000 description 1
108020003589 5' Untranslated Regions Proteins 0.000 description 1
208000026872 Addison Disease Diseases 0.000 description 1
102000002572 Alpha-Globulins Human genes 0.000 description 1
108010068307 Alpha-Globulins Proteins 0.000 description 1
208000003343 Antiphospholipid Syndrome Diseases 0.000 description 1
101100243447 Arabidopsis thaliana PER53 gene Proteins 0.000 description 1
206010003645 Atopy Diseases 0.000 description 1
206010003827 Autoimmune hepatitis Diseases 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
208000009137 Behcet syndrome Diseases 0.000 description 1
208000009299 Benign Mucous Membrane Pemphigoid Diseases 0.000 description 1
208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 1
208000033222 Biliary cirrhosis primary Diseases 0.000 description 1
201000002829 CREST Syndrome Diseases 0.000 description 1
101100257359 Caenorhabditis elegans sox-2 gene Proteins 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
208000031229 Cardiomyopathies Diseases 0.000 description 1
102000020313 Cell-Penetrating Peptides Human genes 0.000 description 1
108010051109 Cell-Penetrating Peptides Proteins 0.000 description 1
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
208000015943 Coeliac disease Diseases 0.000 description 1
208000011038 Cold agglutinin disease Diseases 0.000 description 1
206010009868 Cold type haemolytic anaemia Diseases 0.000 description 1
108010051219 Cre recombinase Proteins 0.000 description 1
208000011231 Crohn disease Diseases 0.000 description 1
208000019707 Cryoglobulinemic vasculitis Diseases 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
241000283086 Equidae Species 0.000 description 1
102100031690 Erythroid transcription factor Human genes 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
102100039556 Galectin-4 Human genes 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
206010072579 Granulomatosis with polyangiitis Diseases 0.000 description 1
208000003807 Graves Disease Diseases 0.000 description 1
208000015023 Graves' disease Diseases 0.000 description 1
208000030836 Hashimoto thyroiditis Diseases 0.000 description 1
101001066268 Homo sapiens Erythroid transcription factor Proteins 0.000 description 1
101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 1
101001023043 Homo sapiens Myoblast determination protein 1 Proteins 0.000 description 1
101000585703 Homo sapiens Protein L-Myc Proteins 0.000 description 1
101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 description 1
201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 description 1
208000010159 IgA glomerulonephritis Diseases 0.000 description 1
206010021263 IgA nephropathy Diseases 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
208000022559 Inflammatory bowel disease Diseases 0.000 description 1
208000003456 Juvenile Arthritis Diseases 0.000 description 1
208000012528 Juvenile dermatomyositis Diseases 0.000 description 1
206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
241000713666 Lentivirus Species 0.000 description 1
206010064281 Malignant atrophic papulosis Diseases 0.000 description 1
208000027530 Meniere disease Diseases 0.000 description 1
229930192392 Mitomycin Natural products 0.000 description 1
208000003250 Mixed connective tissue disease Diseases 0.000 description 1
208000012192 Mucous membrane pemphigoid Diseases 0.000 description 1
241001529936 Murinae Species 0.000 description 1
101100257363 Mus musculus Sox2 gene Proteins 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
208000003926 Myelitis Diseases 0.000 description 1
102100035077 Myoblast determination protein 1 Human genes 0.000 description 1
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
206010029240 Neuritis Diseases 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
241000282520 Papio Species 0.000 description 1
229930040373 Paraformaldehyde Natural products 0.000 description 1
208000018737 Parkinson disease Diseases 0.000 description 1
201000011152 Pemphigus Diseases 0.000 description 1
208000031845 Pernicious anaemia Diseases 0.000 description 1
206010065159 Polychondritis Diseases 0.000 description 1
206010036105 Polyneuropathy Diseases 0.000 description 1
208000012654 Primary biliary cholangitis Diseases 0.000 description 1
102100030128 Protein L-Myc Human genes 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
241000700159 Rattus Species 0.000 description 1
208000012322 Raynaud phenomenon Diseases 0.000 description 1
208000033464 Reiter syndrome Diseases 0.000 description 1
208000025747 Rheumatic disease Diseases 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
101150086694 SLC22A3 gene Proteins 0.000 description 1
206010039710 Scleroderma Diseases 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
208000021386 Sjogren Syndrome Diseases 0.000 description 1
206010072148 Stiff-Person syndrome Diseases 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
101150080074 TP53 gene Proteins 0.000 description 1
208000001106 Takayasu Arteritis Diseases 0.000 description 1
206010043276 Teratoma Diseases 0.000 description 1
108091036066 Three prime untranslated region Proteins 0.000 description 1
206010052779 Transplant rejections Diseases 0.000 description 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
206010046851 Uveitis Diseases 0.000 description 1
206010047115 Vasculitis Diseases 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
239000002253 acid Substances 0.000 description 1
210000004504 adult stem cell Anatomy 0.000 description 1
230000002411 adverse Effects 0.000 description 1
229940035676 analgesics Drugs 0.000 description 1
238000000137 annealing Methods 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
230000001363 autoimmune Effects 0.000 description 1
201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
208000027625 autoimmune inner ear disease Diseases 0.000 description 1
208000036923 autoimmune primary adrenal insufficiency Diseases 0.000 description 1
230000006472 autoimmune response Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
239000012620 biological material Substances 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
208000000594 bullous pemphigoid Diseases 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
239000006143 cell culture medium Substances 0.000 description 1
239000012578 cell culture reagent Substances 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
210000003855 cell nucleus Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
201000010415 childhood type dermatomyositis Diseases 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
201000010002 cicatricial pemphigoid Diseases 0.000 description 1
206010009887 colitis Diseases 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
230000030944 contact inhibition Effects 0.000 description 1
201000003278 cryoglobulinemia Diseases 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
230000003210 demyelinating effect Effects 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
238000013461 design Methods 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
208000037765 diseases and disorders Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
241001493065 dsRNA viruses Species 0.000 description 1
210000003981 ectoderm Anatomy 0.000 description 1
210000002308 embryonic cell Anatomy 0.000 description 1
210000001900 endoderm Anatomy 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
230000003328 fibroblastic effect Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
102000034287 fluorescent proteins Human genes 0.000 description 1
108091006047 fluorescent proteins Proteins 0.000 description 1
210000003953 foreskin Anatomy 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
230000005017 genetic modification Effects 0.000 description 1
235000013617 genetically modified food Nutrition 0.000 description 1
210000001654 germ layer Anatomy 0.000 description 1
239000008103 glucose Substances 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
230000003394 haemopoietic effect Effects 0.000 description 1
238000001794 hormone therapy Methods 0.000 description 1
102000051629 human Lin28A Human genes 0.000 description 1
102000054643 human NANOG Human genes 0.000 description 1
102000047444 human SOX2 Human genes 0.000 description 1
210000002865 immune cell Anatomy 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000006058 immune tolerance Effects 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
208000033065 inborn errors of immunity Diseases 0.000 description 1
238000011534 incubation Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000010354 integration Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
208000036971 interstitial lung disease 2 Diseases 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
230000000366 juvenile effect Effects 0.000 description 1
208000017169 kidney disease Diseases 0.000 description 1
208000002741 leukoplakia Diseases 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
239000003589 local anesthetic agent Substances 0.000 description 1
229960005015 local anesthetics Drugs 0.000 description 1
230000007774 longterm Effects 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
210000003716 mesoderm Anatomy 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
229960004857 mitomycin Drugs 0.000 description 1
230000000394 mitotic effect Effects 0.000 description 1
239000000178 monomer Substances 0.000 description 1
230000004660 morphological change Effects 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
210000000663 muscle cell Anatomy 0.000 description 1
230000035772 mutation Effects 0.000 description 1
208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
206010028417 myasthenia gravis Diseases 0.000 description 1
230000018352 negative regulation of endocytosis Effects 0.000 description 1
230000004770 neurodegeneration Effects 0.000 description 1
208000015122 neurodegenerative disease Diseases 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
238000005457 optimization Methods 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229920002866 paraformaldehyde Polymers 0.000 description 1
210000004738 parenchymal cell Anatomy 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000037361 pathway Effects 0.000 description 1
201000001976 pemphigus vulgaris Diseases 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
210000001778 pluripotent stem cell Anatomy 0.000 description 1
201000006292 polyarteritis nodosa Diseases 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
208000005987 polymyositis Diseases 0.000 description 1
208000019629 polyneuritis Diseases 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
208000028529 primary immunodeficiency disease Diseases 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
210000001938 protoplast Anatomy 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000011535 reaction buffer Substances 0.000 description 1
230000007420 reactivation Effects 0.000 description 1
208000002574 reactive arthritis Diseases 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
210000003289 regulatory T cell Anatomy 0.000 description 1
238000009256 replacement therapy Methods 0.000 description 1
230000001850 reproductive effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
230000000552 rheumatic effect Effects 0.000 description 1
201000003068 rheumatic fever Diseases 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
201000000306 sarcoidosis Diseases 0.000 description 1
230000009758 senescence Effects 0.000 description 1
230000035939 shock Effects 0.000 description 1
238000001542 size-exclusion chromatography Methods 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
230000022379 skeletal muscle tissue development Effects 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
210000000329 smooth muscle myocyte Anatomy 0.000 description 1
238000009168 stem cell therapy Methods 0.000 description 1
238000009580 stem-cell therapy Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
239000013589 supplement Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
201000000596 systemic lupus erythematosus Diseases 0.000 description 1
206010043778 thyroiditis Diseases 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000010474 transient expression Effects 0.000 description 1
230000007704 transition Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
230000032258 transport Effects 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
230000029663 wound healing Effects 0.000 description 1

Images

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/98—Xeno-free medium and culture conditions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/602—Sox-2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/603—Oct-3/4
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/604—Klf-4
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/605—Nanog
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1307—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Organic Chemistry (AREA)
Cell Biology (AREA)
Developmental Biology & Embryology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Transplantation (AREA)
Reproductive Health (AREA)
Virology (AREA)
Immunology (AREA)
Gynecology & Obstetrics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

TW104117573A 2014-05-30 2015-05-29 利用合成之信使ｒｎａ進行之人類誘導型多能幹細胞之無餵養細胞衍化（ｄｅｒｉｖａｔｉｏｎ） TWI698526B (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US14/292,317		2014-05-30
US14/292,317 US10119150B2 (en)	2012-05-13	2014-05-30	Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA

Publications (2)

Publication Number	Publication Date
TW201600605A TW201600605A (zh)	2016-01-01
TWI698526B true TWI698526B (zh)	2020-07-11

Family

ID=54699891

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW104117573A TWI698526B (zh)	2014-05-30	2015-05-29	利用合成之信使ｒｎａ進行之人類誘導型多能幹細胞之無餵養細胞衍化（ｄｅｒｉｖａｔｉｏｎ）

Country Status (7)

Country	Link
KR (1)	KR102361849B1 (fr)
CA (1)	CA2950582C (fr)
IL (1)	IL249193B (fr)
PH (1)	PH12016502343B1 (fr)
SG (1)	SG11201609898WA (fr)
TW (1)	TWI698526B (fr)
WO (1)	WO2015184318A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US12338462B2 (en)	2016-11-16	2025-06-24	Allele Biotechnology And Pharmaceuticals, Inc.	Induction of pancreatic beta cells by stem cell differentiation with RNA
KR102586507B1 (ko)	2016-11-16	2023-10-11	알렐 바이오테크놀로지 앤 파마슈티칼스, 인크.	Ｒｎａ를 사용한 줄기 세포 분화에 의한 간세포의 유도
CN109913494A (zh) *	2019-02-12	2019-06-21	北京呈诺医学科技有限公司	一种新的ips细胞的诱导方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012012708A1 (fr) *	2010-07-22	2012-01-26	Regents Of The University Of Minnesota	Cellules souches pluripotentes induites

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2010108126A2 (fr) *	2009-03-19	2010-09-23	Fate Therapeutics, Inc.	Compositions de reprogrammation et procédés d'utilisation de celles-ci
AU2013222188A1 (en) *	2012-02-22	2014-09-11	Amgen Inc.	Autologous mammalian models derived from induced pluripotent stem cells and related methods
US10155929B2 (en) *	2012-05-13	2018-12-18	Allele Biotechnology & Pharmaceuticals, Inc.	Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA

2015
- 2015-05-29 CA CA2950582A patent/CA2950582C/fr active Active
- 2015-05-29 SG SG11201609898WA patent/SG11201609898WA/en unknown
- 2015-05-29 TW TW104117573A patent/TWI698526B/zh active
- 2015-05-29 PH PH1/2016/502343A patent/PH12016502343B1/en unknown
- 2015-05-29 KR KR1020167036491A patent/KR102361849B1/ko active Active
- 2015-05-29 WO PCT/US2015/033275 patent/WO2015184318A1/fr not_active Ceased
2016
- 2016-11-24 IL IL249193A patent/IL249193B/en active IP Right Grant

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012012708A1 (fr) *	2010-07-22	2012-01-26	Regents Of The University Of Minnesota	Cellules souches pluripotentes induites

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Rosa A1, Brivanlou AH.,Synthetic mRNAs: powerful tools for reprogramming and differentiation of human cells.,Cell Stem Cell.2010 Nov 5;7(5):p.549-550. *

Also Published As

Publication number	Publication date
TW201600605A (zh)	2016-01-01
CA2950582C (fr)	2020-09-22
CA2950582A1 (fr)	2015-12-03
KR20170023014A (ko)	2017-03-02
PH12016502343B1 (en)	2023-02-01
SG11201609898WA (en)	2016-12-29
KR102361849B1 (ko)	2022-02-11
IL249193A0 (en)	2017-01-31
IL249193B (en)	2020-05-31
PH12016502343A1 (en)	2017-02-13
WO2015184318A1 (fr)	2015-12-03

Publication	Publication Date	Title
US10435711B2 (en)	2019-10-08	Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA
AU2019203335B2 (en)	2021-10-21	Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA
US10155929B2 (en)	2018-12-18	Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA
TWI698526B (zh)	2020-07-11	利用合成之信使ｒｎａ進行之人類誘導型多能幹細胞之無餵養細胞衍化（ｄｅｒｉｖａｔｉｏｎ）
JP2019170405A (ja)	2019-10-10	合成メッセンジャーｒｎａによるヒト人工多能性幹細胞のフィーダーフリー誘導
HK40015744B (en)	2023-09-22	Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna
HK40015744A (en)	2020-09-04	Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna
HK40013817A (en)	2020-08-14	Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna
HK1204005B (zh)	2020-05-08	使用合成的信使rna无饲养细胞地衍生人类诱导性多能干细胞
HK40013817B (en)	2023-07-28	Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna